1 Scientific and Medical Division, European Society for Medical Oncology (ESMO), Lugano, Switzerland. Electronic address: [email protected].
2 Department of Gastroenterology and Digestive Oncology, Hôpital Cochin AP-HP, Université Paris Cité, Paris; Centre d'Épidémiologie Clinique, Hôtel Dieu, Paris, France.
3 Scientific and Medical Division, European Society for Medical Oncology (ESMO), Lugano, Switzerland; Université Libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), Institut Jules Bordet, Academic Trials Promoting Team (ATPT), Brussels, Belgium.
4 Department of Oncology, Faculty of Medicine and Health, Örebro University Hospital, Örebro University, Örebro, Sweden.
5 Julius Center for Health Sciences and Primary Care, Department of Epidemiology and Health Economics, University Medical Centre Utrecht, Utrecht University, Utrecht.
6 Department of Medical Oncology, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.
7 Laboratory of Biostatistics, Department of Nursing, National and Kapodistrian University of Athens, Athens; Frontier Science Foundation Hellas, Athens, Greece.
8 Frontier Science Foundation Hellas, Athens, Greece.
9 Department of Gastroenterology, Hepatology and Endocrinology, Medical School of Hannover, Hannover, Germany; Toronto Center of Liver Disease, Toronto General Hospital, University Health Network, Toronto; Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada.
10 AI-ON-Lab, Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan; NEARLab, Department of Electronics, Information and Bioengineering, Politecnico di Milano, Milan, Italy.
11 Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
12 Business Research Unit, ISCTE Business School, ISCTE-IUL, Lisbon, Portugal.
14 ICR-CTSU, Division of Clinical Studies, The Institute of Cancer Research, London, UK.
15 Else Kroener Fresenius Center for Digital Health, Technical University Dresden, Dresden; Medical Oncology, National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.
16 Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, Málaga, Spain.
17 Clinical Trial Unit, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy.
18 Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
19 Oncoclinicas Precision Medicine, Oncoclinicas Group, São Paulo, Brazil; Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
20 Department of Oncology; Department of Public Health Sciences, Queen's University, Kingston, Canada.
21 Scientific and Medical Division, European Society for Medical Oncology (ESMO), Lugano, Switzerland.
22 Department of Cancer Medicine, Gustave Roussy, Villejuif, France.